Targeting an Achilles' heel of cancer with a WRN helicase inhibitor.

Abstract

Our recently published work suggests that DNA helicases such as the Werner syndrome helicase (WRN) represent a novel class of proteins to target for anticancer therapy. Specifically, pharmacological inhibition of WRN helicase activity in human cells defective in the Fanconi anemia (FA) pathway of interstrand cross-link (ICL) repair are sensitized to the DNA cross-linking agent and chemotherapy drug mitomycin C (MMC) by the WRN helicase inhibitor NSC 617145. (1) The mechanistic basis for the synergistic interaction between NSC 617145 and MMC is discussed in this paper and extrapolated to potential implications for genetic or chemically induced synthetic lethality provoked by cellular exposure to the WRN helicase inhibitor under the context of relevant DNA repair deficiencies associated with cancers or induced by small-molecule inhibitors. Experimental data are presented showing that small-molecule inhibition of WRN helicase elevates sensitivity to MMC-induced stress in human cells that are deficient in both FANCD2 and DNA protein kinase catalytic subunit (DNA-PKcs). These findings suggest a model in which drug-mediated inhibition of WRN helicase activity exacerbates the deleterious effects of MMC-induced DNA damage when both the FA and NHEJ pathways are defective. We conclude with a perspective for the FA pathway and synthetic lethality and implications for DNA repair helicase inhibitors that can be developed for anticancer strategies.

• Authors: Monika Aggarwal, Taraswi Banerjee, Joshua A Sommers, Robert M Brosh Jr
• Journal: Cell cycle (Georgetown, Tex.) (Cell Cycle) Vol. 12 Issue 20 Pg. 3329-35 (Oct 15 2013) ISSN: 1551-4005 [Electronic] United States
• PMID: 24036544 (Publication Type: Journal Article, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't)

Chemical References

• Enzyme Inhibitors
• Maleimides
• NSC 617145
• Mitomycin
• RecQ Helicases

Topics

• Cell Line
• DNA End-Joining Repair (drug effects)
• Enzyme Inhibitors (pharmacology)
• Fanconi Anemia (enzymology, pathology)
• Humans
• Maleimides (pharmacology)
• Mitomycin (pharmacology)
• Models, Biological
• Neoplasms (enzymology, pathology)
• RecQ Helicases (antagonists & inhibitors, metabolism)
• Signal Transduction (drug effects)
• Stress, Physiological (drug effects)